3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      IC3D Classification of Corneal Dystrophies—Edition 3

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Purpose:

          The International Committee for the Classification of Corneal Dystrophies (IC3D) was created in 2005 to develop a new classification system integrating current information on phenotype, histopathology, and genetic analysis. This update is the third edition of the IC3D nomenclature.

          Methods:

          Peer-reviewed publications from 2014 to 2023 were evaluated. The new information was used to update the anatomic classification and each of the 22 standardized templates including the level of evidence for being a corneal dystrophy [from category 1 (most evidence) to category 4 (least evidence)].

          Results:

          Epithelial recurrent erosion dystrophies now include epithelial recurrent erosion dystrophy, category 1 ( COL17A1 mutations, chromosome 10). Signs and symptoms are similar to Franceschetti corneal dystrophy, dystrophia Smolandiensis, and dystrophia Helsinglandica, category 4. Lisch epithelial corneal dystrophy, previously reported as X-linked, has been discovered to be autosomal dominant ( MCOLN1 mutations, chromosome 19). Classic lattice corneal dystrophy (LCD) results from TGFBI R124C mutation. The LCD variant group has over 80 dystrophies with non-R124C TGFBI mutations, amyloid deposition, and often similar phenotypes to classic LCD. We propose a new nomenclature for specific LCD pathogenic variants by appending the mutation using 1-letter amino acid abbreviations to LCD. Pre-Descemet corneal dystrophies include category 1, autosomal dominant, punctiform and polychromatic pre-Descemet corneal dystrophy (PPPCD) ( PRDX3 mutations, chromosome 10). Typically asymptomatic, it can be distinguished phenotypically from pre-Descemet corneal dystrophy, category 4. We include a corneal dystrophy management table.

          Conclusions:

          The IC3D third edition provides a current summary of corneal dystrophy information. The article is available online at https://corneasociety.org/publications/ic3d.

          Related collections

          Most cited references50

          • Record: found
          • Abstract: found
          • Article: not found

          Descemet Membrane Endothelial Keratoplasty: Safety and Outcomes

          To review the published literature on the safety and outcomes of Descemet membrane endothelial keratoplasty (DMEK) for the surgical treatment of corneal endothelial dysfunction.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The IC3D classification of the corneal dystrophies.

            The recent availability of genetic analyses has demonstrated the shortcomings of the current phenotypic method of corneal dystrophy classification. Abnormalities in different genes can cause a single phenotype, whereas different defects in a single gene can cause different phenotypes. Some disorders termed corneal dystrophies do not appear to have a genetic basis. The purpose of this study was to develop a new classification system for corneal dystrophies, integrating up-to-date information on phenotypic description, pathologic examination, and genetic analysis. The International Committee for Classification of Corneal Dystrophies (IC3D) was created to devise a current and accurate nomenclature. This anatomic classification continues to organize dystrophies according to the level chiefly affected. Each dystrophy has a template summarizing genetic, clinical, and pathologic information. A category number from 1 through 4 is assigned, reflecting the level of evidence supporting the existence of a given dystrophy. The most defined dystrophies belong to category 1 (a well-defined corneal dystrophy in which a gene has been mapped and identified and specific mutations are known) and the least defined belong to category 4 (a suspected dystrophy where the clinical and genetic evidence is not yet convincing). The nomenclature may be updated over time as new information regarding the dystrophies becomes available. The IC3D Classification of Corneal Dystrophies is a new classification system that incorporates many aspects of the traditional definitions of corneal dystrophies with new genetic, clinical, and pathologic information. Standardized templates provide key information that includes a level of evidence for there being a corneal dystrophy. The system is user-friendly and upgradeable and can be retrieved on the website www.corneasociety.org/ic3d.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              IC3D classification of corneal dystrophies--edition 2.

              To update the 2008 International Classification of Corneal Dystrophies (IC3D) incorporating new clinical, histopathologic, and genetic information.
                Bookmark

                Author and article information

                Contributors
                Journal
                Cornea
                Cornea
                cornea
                Cornea
                Cornea
                0277-3740
                1536-4798
                April 2024
                12 February 2024
                : 43
                : 4
                : 466-527
                Affiliations
                [* ]Departments of Ophthalmology, Pathology and Pharmacology, Louisiana State University Eye Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA;
                []Cornea Service, Wills Eye Hospital, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA;
                []Department of Ophthalmology, Saarland University Medical Center, Homburg/Saar, Germany;
                [§ ]Department of Translational Medicine, University of Ferrara, Ferrara, Italy;
                []Istituto Internazionale per la Ricerca e Formazione in Oftalmologia, Forlì, Italy;
                []Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland;
                [** ]Department of Ophthalmology, Quinze-Vingts National Ophthalmology Hospital and Sorbonne Université, Paris, France;
                [†† ]Department of Clinical Medicine, University of Bergen, Bergen, Norway;
                [‡‡ ]Division of Pediatric Ophthalmology, Strabismus and Adult Motility, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, Pittsburgh, PA;
                [§§ ]Department of Ophthalmology, Louisiana State University Health Sciences Center, New Orleans, LA;
                [¶¶ ]Department of Ophthalmology, Tufts University School of Medicine and Harvard Medical School, Schepens Eye Research Institute and New England Eye Center, Boston, MA;
                [║║ ]Corneal Dystrophy Research Institute, Yonsei University College of Medicine, Seoul, Korea;
                [*** ]Saevit Eye Hospital, Goyang, Korea;
                [††† ]Department of Pediatric Ophthalmology, Aarhus University Hospital, Aarhus, Denmark;
                [‡‡‡ ]Retinoblastoma and Oculogenetic Units, Jules-Gonin Eye Hospital and Fondation Asile des Aveugle, University of Lausanne, Lausanne, Switzerland; and
                [§§§ ]Department of Ophthalmology, Johannes Gutenberg University Mainz, Mainz, Germany.
                Author notes
                Correspondence: Jayne S. Weiss MD, Department of Ophthalmology, LSU School of Medicine, 533 Bolivar St, Room 459, New Orleans, LA 70112 (e-mail: jweiss@ 123456lsuhsc.edu ).
                Article
                CORNEA-D-23-00685 00012
                10.1097/ICO.0000000000003420
                10906208
                38359414
                9e8ff1a1-deb6-4b74-b15c-00bd45dfbbbb
                Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.

                This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

                History
                : 03 August 2023
                : 08 September 2023
                : 24 September 2023
                Categories
                Special Article
                Custom metadata
                TRUE

                corneal dystrophy,inherited corneal diseases,cornea,cornea pathology,genetic disease

                Comments

                Comment on this article